MiNK Therapeutics Book Value Per Share Growth & History (INKT)
MiNK Therapeutics's book value per share was -$3.02 for fiscal 2025.
View full MiNK Therapeutics company overviewMiNK Therapeutics annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | -$3.02 | $1.92 | — |
| 2024 | 2024-12-31 | -$4.94 | $0.28 | — |
| 2023 | 2023-12-31 | -$5.22 | -$4.03 | — |
| 2022 | 2022-12-31 | -$1.19 | -$72.21 | — |
| 2021 | 2021-12-31 | $71.02 | $294.49 | — |
| 2020 | 2020-12-31 | -$223.47 | — | — |
MiNK Therapeutics quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$2.75 | $2.82 | — |
| Q1 2026 | 2026-03-31 | -$2.55 | $2.92 | — |
| Q4 2025 | 2025-12-31 | -$3.02 | $1.92 | — |
| Q3 2025 | 2025-09-30 | -$2.88 | $41.51 | — |
| Q2 2025 | 2025-06-30 | -$5.57 | $36.35 | — |
| Q1 2025 | 2025-03-31 | -$5.47 | $52.99 | — |
| Q4 2024 | 2024-12-31 | -$4.94 | $0.28 | — |
| Q3 2024 | 2024-09-30 | -$44.38 | -$5.04 | — |
| Q2 2024 | 2024-06-30 | -$41.92 | -$14.41 | — |
| Q1 2024 | 2024-03-31 | -$58.45 | -$45.45 | — |
| Q4 2023 | 2023-12-31 | -$5.22 | -$4.03 | — |
| Q3 2023 | 2023-09-30 | -$39.34 | -$59.34 | — |
| Q2 2023 | 2023-06-30 | -$27.52 | -$68.05 | — |
| Q1 2023 | 2023-03-31 | -$13.00 | -$64.58 | — |
| Q4 2022 | 2022-12-31 | -$1.19 | -$72.21 | — |
| Q3 2022 | 2022-09-30 | $20.00 | $248.36 | — |
| Q2 2022 | 2022-06-30 | $40.53 | — | — |
| Q1 2022 | 2022-03-31 | $51.57 | — | — |
| Q4 2021 | 2021-12-31 | $71.02 | — | — |
| Q3 2021 | 2021-09-30 | -$228.36 | — | — |
MiNK Therapeutics book value per share trends
Over the last five fiscal years, MiNK Therapeutics's book value per share increased from -$223.47 to -$3.02, a change of $220.44. The latest reported quarter, Q2 2026, shows -$2.75.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review MiNK Therapeutics source filings ↗